Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
AVR Anteris Technologies Global
- 4.910
- +0.430+9.60%
Trading Apr 24 11:13 ET
176.88MMarket Cap-2.31P/E (TTM)
4.960High4.500Low93.47KVolume4.500Open4.480Pre Close441.17KTurnover0.63%Turnover RatioLossP/E (Static)36.02MShares8.79052wk High2.82P/B73.05MFloat Cap2.34052wk Low--Dividend TTM14.88MShs Float8.790Historical High--Div YieldTTM10.26%Amplitude2.340Historical Low4.719Avg Price1Lot Size
Anteris Technologies Global Key Stats
Quarterly+Annual
YOY
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | (FY)Dec 30, 2018 | (FY)Dec 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.49%2.7M | -10.30%2.8M | -44.71%3.12M | -20.47%5.65M | -40.59%7.1M | -33.71%11.95M | 104.51%18.03M | -16.55%8.82M | 35.96%10.57M | 4.50%7.77M |
| Operating revenue | -3.49%2.7M | -10.30%2.8M | -44.71%3.12M | -20.47%5.65M | -40.59%7.1M | -33.71%11.95M | 104.51%18.03M | -16.55%8.82M | 35.96%10.57M | 4.50%7.77M |
| Cost of revenue | 32.33%1.44M | -19.44%1.09M | 13.39%1.35M | -43.22%1.19M | -65.91%2.09M | -33.76%6.14M | 156.36%9.27M | -46.36%3.62M | 44.11%6.74M | 2.62%4.68M |
| Gross profit | -26.18%1.27M | -3.36%1.71M | -60.20%1.77M | -10.96%4.46M | -13.84%5.01M | -33.66%5.81M | 68.45%8.76M | 35.98%5.2M | 23.63%3.83M | 7.47%3.09M |
| Operating expense | 62.40%80.94M | 46.53%49.84M | 60.90%34.01M | 17.83%21.14M | -24.36%17.94M | -5.70%23.72M | 106.00%25.15M | -53.18%12.21M | 17.59%26.07M | 33.36%22.17M |
| Selling and administrative expenses | 12.97%28.19M | 55.21%24.95M | 52.93%16.08M | 10.62%10.51M | -39.45%9.5M | -5.29%15.69M | 93.12%16.57M | -30.75%8.58M | 15.19%12.39M | 24.81%10.76M |
| -Selling and marketing expense | 2,405.98%28.19M | 39.97%1.12M | 101.70%803.6K | -12.85%398.4K | -55.62%457.14K | --1.03M | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | 56.02%23.83M | 51.01%15.27M | 11.81%10.11M | -38.31%9.05M | -11.51%14.66M | 93.12%16.57M | -30.75%8.58M | 15.19%12.39M | 29.86%10.76M |
| Research and development costs | 230.49%51.45M | 73.18%15.57M | 54.77%8.99M | 63.00%5.81M | 53.52%3.56M | -2.31%2.32M | 409.75%2.38M | -87.01%466.09K | 83.84%3.59M | 10.00%1.95M |
| Depreciation amortization depletion | -31.61%1.3M | 60.41%1.9M | 20.72%1.19M | 5.29%981.66K | -17.62%932.3K | 13.88%1.13M | 41.88%993.75K | -39.25%700.39K | -25.47%1.15M | 12.31%1.55M |
| -Depreciation and amortization | -31.61%1.3M | 60.41%1.9M | 20.72%1.19M | 5.29%981.66K | -17.62%932.3K | 13.88%1.13M | 41.88%993.75K | -39.25%700.39K | -25.47%1.15M | 12.31%1.55M |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 239.53%13.02K |
| Other operating expenses | ---- | -4.44%7.42M | 102.32%7.76M | -2.68%3.84M | -13.76%3.94M | -12.27%4.57M | 111.62%5.21M | -72.47%2.46M | 13.11%8.94M | 62.87%7.91M |
| Operating profit | -65.56%-79.67M | -49.28%-48.12M | -93.28%-32.24M | -28.97%-16.68M | 27.77%-12.93M | -9.25%-17.9M | -133.88%-16.39M | 68.51%-7.01M | -16.61%-22.25M | -38.78%-19.08M |
| Net non-operating interest income expense | 232.78%383K | 121.99%115.09K | 49.26%-523.34K | -240.50%-1.03M | 7.43%-302.89K | 82.11%-327.22K | -1,000.28%-1.83M | -341.15%-166.23K | 379.52%68.93K | -62.33%14.38K |
| Non-operating interest income | -1.72%430K | 108.50%437.54K | 216.73%209.85K | -53.42%66.25K | 209.46%142.25K | 55.96%45.97K | -4.75%29.47K | -75.01%30.94K | 77.48%123.83K | 82.86%69.77K |
| Non-operating interest expense | -57.48%47K | -82.21%110.53K | -36.13%621.13K | 239.77%972.47K | 41.12%286.22K | -89.09%202.82K | 842.55%1.86M | 259.15%197.17K | -0.90%54.9K | --55.4K |
| Total other finance cost | ---- | 89.11%211.92K | -10.46%112.06K | -21.25%125.15K | -6.71%158.93K | --170.36K | ---- | ---- | ---- | ---- |
| Other net income (expense) | 114.54%2.02M | -63.69%942.47K | 135.01%2.6M | -25.92%1.1M | -89.28%1.49M | 1,599.24%13.9M | 185.59%818.19K | -91.60%286.5K | 351.30%3.41M | -82.01%756.11K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---3.35M | ---- | ---- | ---- | -7.72%-143.42K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | --3.14M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --213.12K | ---- | ---- | ---- | 7.72%143.42K |
| Other non- operating income (expenses) | 114.54%2.02M | -63.69%942.47K | 135.01%2.6M | -25.92%1.1M | -91.36%1.49M | 2,008.50%17.25M | 185.59%818.19K | -91.60%286.5K | 279.34%3.41M | -79.26%899.53K |
| Income before tax | -61.41%-75.97M | -56.03%-47.06M | -81.65%-30.16M | -41.40%-16.61M | -171.38%-11.74M | 75.13%-4.33M | -152.64%-17.4M | 63.31%-6.89M | -2.50%-18.77M | -92.58%-18.31M |
| Income tax | 0 | -127.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 226.22%2.25M |
| Net income | -61.85%-75.97M | -55.60%-46.94M | -81.65%-30.16M | -41.40%-16.61M | -171.38%-11.74M | 75.13%-4.33M | -152.64%-17.4M | 63.31%-6.89M | 8.70%-18.77M | -166.00%-20.56M |
| Net income continuous Operations | -61.85%-75.97M | -55.60%-46.94M | -81.65%-30.16M | -41.40%-16.61M | -171.38%-11.74M | 75.13%-4.33M | -152.64%-17.4M | 63.31%-6.89M | 8.70%-18.77M | -166.00%-20.56M |
| Minority interest income | 130.49%324K | -1.06M | 25.34%-253.22K | -120.97%-339.17K | 81.59%-153.5K | 29.69%-833.81K | 20.84%-1.19M | |||
| Net income attributable to the parent company | -66.30%-76.29M | -52.08%-45.87M | -81.65%-30.16M | -41.40%-16.61M | -188.25%-11.74M | 76.12%-4.07M | -153.36%-17.06M | 62.46%-6.73M | 7.42%-17.93M | -210.94%-19.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -66.30%-76.29M | -52.08%-45.87M | -81.65%-30.16M | -41.40%-16.61M | -188.25%-11.74M | 76.12%-4.07M | -153.36%-17.06M | 62.46%-6.73M | 7.42%-17.93M | -210.94%-19.37M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now